1,543
Views
25
CrossRef citations to date
0
Altmetric
Research Paper

Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma

, , , , , , , , , & show all
Pages 812-825 | Received 06 Sep 2018, Accepted 25 Dec 2018, Published online: 06 Feb 2019

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. 87-10 doi:10.3322/caac.21262. PMID: 25651787.
  • El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–1273. PMID: 22537432. doi:10.1053/j.gastro.2011.12.061.
  • Padhy AK, Dondi M. A report on the implementation aspects of the international atomic energy agency’s first doctoral coordinated research project, “management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry”. Semin Nucl Med. 2008;38(2):S5–12. PMID: 18243843. doi:10.1053/j.semnuclmed.2007.10.002.
  • Wang K, Eguchi S, Hidaka M, Jin T, Soyama A, Kuroki T, Huang M, Wu L, Zou S, Shao J. Comparison of the outcomes of hepatocellular carcinoma after hepatectomy between two regional medical centers in China and Japan. Asian J Surg. 2017;40(5):380–388. PMID: 27236717. doi:10.1016/j.asjsur.2016.03.002.
  • Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42(Suppl. 3):S206–214. PMID: 20547305. doi:10.1016/S1590-8658(10)60507-5.
  • Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg. 2004;198(3):356–365. PMID: 14992736. doi:10.1016/j.jamcollsurg.2003.10.017.
  • Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg. 2004;21(5–6):380–386. PMID: 15523181. doi:10.1159/000081882.
  • Zhang S, Xue H, Chen Q. Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer. Oncotarget. 2016;7(36):58579–58585. PMID: 27409828. doi:10.18632/oncotarget.10463.
  • Chen JH, Kim SH, Fan PW, Liu CY, Hsieh CH, Fang K. The aqueous extract of chinese medicinal herb brucea javanica suppresses the growth of human liver cancer and the derived stem-like cells by apoptosis. Drug Des Devel Ther. 2016;10:2003–2013. PMID: 27382253. doi:10.2147/DDDT.S107909.
  • Yang TS, Chang HK, Chen JS, Lin YC, Liau CT, Chang WC. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. J Gastroenterol. 2004;39(4):362–369. PMID: 15168248. doi:10.1007/s00535-003-1303-8.
  • Juzenas P, Moan J. Singlet oxygen in photosensitization. J Environ Pathol Toxicol Oncol. 2006;25(1–2):29–50. PMID: 16566709.
  • Barr H. Photodynamic therapy in gastrointestinal cancer: a realistic option? Drugs Aging. 2000;16 PMID: 10755325 (2):81–86. doi:10.2165/00002512-200016020-00001.
  • Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother. 2001;2(6):917–927. PMID: 11585008. doi:10.1517/14656566.2.6.917.
  • Mg V. Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. Curr Med Chem Anticancer Agents. 2001;1 PMID: 12678766 (2):175–194. doi:10.2174/1568011013354769.
  • Bc W. Photodynamic therapy for cancer: principles. Can J Gastroenterol. 2002;16 PMID: 12096303 (6):393–396. doi:10.1155/2002/743109.
  • Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42 PMID: 10688709 (3):389–413. doi:10.1016/S0190-9622(00)90209-3.
  • Wu DQ, Li ZY, Li C, Fan JJ, Lu B, Chang C, Cheng SX, Zhang XZ, Zhuo RX. Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy. Pharm Res. 2010;27(1):187–199. PMID: 19888639. doi:10.1007/s11095-009-9998-8.
  • Choi J, Kim H, Choi Y. Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of briple-negative breast cancer. Quant Imaging Med Surg. 2015;5(5):656–664. PMID: 26682135. doi:10.3978/j.issn.2223-4292.2015.08.09.
  • El-Hussein A, Mfouo-Tynga I, Abdel-Harith M, Abrahamse H. Comparative study between the photodynamic ability of gold and silver nanoparticles in mediating cell death in breast and lung cancer cell lines. J Photochem Photobiol B. 2015;153:67–75. PMID: 26398813. doi:10.1016/j.jphotobiol.2015.08.028.
  • Cheng Y, Cheng H, Jiang C, Qiu X, Wang K, Huan W, Yuan A, Wu J, Hu Y. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat Commun. 2015;6:8785. PMID: 26525216. doi:10.1038/ncomms9785.
  • Seong DY, Kim YJ. Enhanced photodynamic therapy efficacy of methylene blue-loaded calcium phosphate nanoparticles. J Photochem Photobiol B. 2015;146:34–43. PMID: 25794464. doi:10.1016/j.jphotobiol.2015.02.022.
  • Lun M, Wei C, Gabriele S, Wei W, Alan GJ, Yining H, Ramaswami S, Marius H. A new Cu-cysteamine complex: structure and optical properties. J Mater Chem C. 2014;2:4239–4246. doi:10.1039/C4TC00114A.
  • Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol. 2014; 10(8):1501–1508. PMID: 25016650 doi:10.1166/jbn.2014.1954.
  • Yao M, Ma L, Li L, Zhang J, Lim RX, Chen W, Zhang Y. A new modality for cancer treatment—nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol. 2016;12 PMID: 29359896 (10):1835–1851. doi:10.1166/jbn.2016.2322.
  • Liu Z, Xiong L, Ouyang G, Ma L, Sahi S, Wang K, Lin L, Huang H, Miao X. The investigation of copper cysteamine nanoparticles as a new type of radiosenstizers for colorectal carcinoma. Sci Rep. 2017;7(1):9290. PMID: 28839163. doi:10.1038/s41598-017-09375-y.
  • Sun Z, Wang L, Dong L, Wang X. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium. J Cell Mol Med. 2018;22:3719–3728. PMID: 29799161. doi:10.1111/jcmm.13676.
  • Tucher C, Bode K, Schiller P, Claßen L, Birr C, Mm S-C, Blank N, Hm L, Schiller M. Extracellular vesicle subtypes released from activated or apoptotic t-lymphocytes carry a specific and stimulus-dependent protein cargo. Front Immunol. 2018;9:534. PMID: 29599781. doi:10.3389/fimmu.2018.00534.
  • Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Tumour Biol. 2015;36(6):4643–4653. PMID: 25631748. doi:10.1007/s13277-015-3112-0.
  • Yn K, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B. 2002;66(2):89–106. PMID: 11897509.
  • Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, Hasan T. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010;110(5):2795–2838. PMID: 20353192. doi:10.1021/cr900300p.
  • Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55(1):145–157. PMID: 1603846.
  • Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–387. PMID: 12724736. doi:10.1038/nrc1071.
  • Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res. 1998;150(5 Suppl):S146–156. PMID: 9806617.
  • Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci. 2002;1(1):1–21. PMID: 12659143.
  • Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis Photodyn Ther. 2005;2(2):91–106. PMID: 25048669. doi:10.1016/S1572-1000(05)00060-8.
  • Feng L, Zhu J, Wang Z. Biological functionalization of conjugated polymer nanoparticles for targeted imaging and photodynamic killing of tumor cells. ACS Appl Mater Interfaces. 2016;8(30):19364–19370. PMID: 27406913. doi:10.1021/acsami.6b06642.
  • Rene HD, Badireddy AR, José MS, Francisco CC, Israel MG, Isela SN, Chellam S, Claudio CR. Cytotoxic effect of lipophilic bismuth dimercaptopropanol nanoparticles on epithelial cells. J Nanosci Nanotechnol. 2016;16(1):203–209. PMID: 27398446.
  • Mirzaie ZH, Irani S, Mirfakhraie R, Atyabi SM, Dinarvand M, R D, Varshochian R, Atyabi F. Docetaxel-chitosan nanoparticles for breast cancer cell treatment: cell viability and gene expression study. Chem Biol Drug Des. 2016;88(6):850–858. PMID: 27390258. doi:10.1111/cbdd.12814.
  • Drews J, Ryser S. The role of innovation in drug development. Nat Biotechnol. 1997;15(13):1318–1319. PMID: 9415870. doi:10.1038/nbt1297-1318.
  • Krammer B. Vascular effects of photodynamic therapy. Anticancer Res. 2001;21(6B):4271–4277. PMID: 11908681.
  • Dolmans DE, Kadambi A, Hill JS, Waters CA, Robinson BC, Walker JP, Fukumura D, Jain RK. Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res. 2002;62(7):2151–2156. PMID: 11929837.
  • Kopbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14(5):329–334. PMID: 9612200. doi:10.1089/clm.1996.14.329.
  • Hanlon JG, Adams K, Rainbow AJ, Gupta RS, Singh G. Induction of Hsp60 by photofrin-mediated photodynamic therapy. J Photochem Photobiol B. 2001;64(1):55–61. PMID: 11705730.
  • Van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology. 2003;207(2):105–113. PMID: 12675268. doi:10.1078/0171-2985-00221.
  • Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Na Rev Cancer. 2006;6(7):535–545. PMID: 16794636. doi:10.1038/nrc1894.
  • Patterson MS, Madsen SJ, Wilson BC. Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. J Photochem Photobiol B. 1990;5(1):69–84. PMID: 2111394.
  • Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976;36(7/1):2326–2329. PMID: 1277137.
  • Krasnovsky AA Jr. Singlet molecular oxygen in photobiochemical systems: ir phosphorescence studies. Membr Cell Biol. 1998;12(5):665–690. PMID: 10379647.
  • Niedre M, Patterson MS, Wilson BC. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem Photobiol. 2002;75(4):382–391. PMID: 12003128. doi:10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2.
  • Baier J, Maisch T, Maier M, Landthaler M, Bäumler W. Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin. J Invest Dermatol. 2007;127(6):1498–1506. PMID: 17363921. doi:10.1038/sj.jid.5700741.
  • Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther. 2004;1(4):279–293. PMID: 25048432. doi:10.1016/S1572-1000(05)00007-4.
  • Ferreira SD, Tedesco AC, Sousa G, Zângaro RA, Silva NS, Pacheco MT, Pacheco-Soares C. Analysis of mitochondria, endoplasmic reticulum and actin filaments after PDT with AlPcS(4). Lasers Med Sci. 2004;18(4):207–212. PMID: 15042425. doi:10.1007/s10103-003-0282-6.
  • Chiu SM, Oleinick NL. Dissociation of mitochondrial depolarization from cytochrome C release during apoptosis induced by photodynamic therapy. Br J Cancer. 2001;84(8):1099–1106. PMID: 11308261. doi:10.1054/bjoc.2000.1714.
  • Granville DJ, Cassidy BA, Ruehlmann DO, Choy JC, Brenner C, Kroemer G, van Breemen C, Margaron P, Hunt DW, McManus BM. Mitochondrial release of aapoptosis-inducing factor and cytochrome C during smooth muscle cell apoptosis. Am J Pathol. 2001;159(1):305–311. PMID: 11438477. doi:10.1016/S0002-9440(10)61696-3.
  • Kantaei C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta. 2011;1813(4):558–563. PMID: 21295084. doi:10.1016/j.bbamcr.2011.01.026.
  • Yoo JO, Lim YC, Kim YM, Ha KS. Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/bax protein signaling pathway. J Biol Chem. 2012;287(18):14377–14388. PMID: 22418443. doi:10.1074/jbc.M111.326074.
  • Marino J, García Vior MC, Furmento VA, Blank VC, Awruch J, Roguin LP. Lysosomal and mitochondrial permeabilization mediates zinc(ii) cationic phthalocyanine phototoxicity. Int J Biochem Cell Biol. 2013;45(11):2553–2562. PMID: 23994488. doi:10.1016/j.biocel.2013.08.012.
  • Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q, Shen G. 2016. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. Tumour Biol. 37:7589–7597. doi:10.1007/s13277-015-4642-1.
  • Larue L, Ben Mihoub A, Youssef Z, Colombeau L, Acherar S, André JC, Arnoux P, Baros F, Vermandel M. Using X-rays in photodynamic therapy: an overview. Photochem Photobiol Sci. 2018;17:1612–1650. PMID: 29938265. doi:10.1039/c8pp00112j.
  • Kooijmans SA, Achiffelers RM, Zarovni N, Vago R. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment. Pharmacol Res. 2016;111:487–500. PMID: 27394168. doi:10.1016/j.phrs.2016.07.006.
  • Lunavat TR, Jang SC, Nilsson L, Park HT, Repiska G, Lässer C, Nilsson JA, Gho YS, Lötvall J. RNAi delivery by exosome-mimetic nanovesicles – implications for targeting c-Myc in cancer. Biomaterials. 2016;102:231–238. PMID: 27344366. doi:10.1016/j.biomaterials.2016.06.024.
  • Pass HI. Photodynamic therapy in on1cology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85 PMID: 8445672 (6):443–456. doi:10.1093/jnci/85.6.443.
  • Moore CM, Pendse D, Emberton M. Photodynamic therapy for prostate cancer—a review of ccurrent status and future promise. Nat Clin Pract Urol. 2009;6(1):18–30. PMID: 19132003. doi:10.1038/ncpuro1274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.